International Journal of Tuberculosis and Lung Disease

Article	Citations
TB infection in adults with diabetes mellitus in Uganda	126
Clinical profile and outcomes of paediatric central nervous system tuberculomas	102
TB-related deaths among adults in Guinea-Bissau	75
Launch of a second wave of IJTLD Clinical Standards for Lung Health	50
Ethambutol-induced optic neuropathy: should we mandate ophthalmic examination in TB treatment?	45
Dr Christopher Zishiri	41
The impact of sputum quality on Xpert positivity in active case-finding for TB	39
Travel reimbursements, distance to health facility and preventive treatment cascade for drug-resistant TB	39
Screening of refugees from Ukraine for TB: a TBnet survey	29
Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo	28
Reply to ‘Estimating TB survival ‐ mind the immortal-time gap’	27
Atorvastatin to reduce bacillary load and attenuate lung damage in TB patients	27
The effect of antenatal isoniazid preventive therapy on birth outcomes in Western Kenya	26
Targeted therapeutic drug monitoring identifies frequent under-dosing of TB drugs	25
Cost-effectiveness of pretomanid-based regimen for highly drug- resistant TB in a low-burden setting	24
Latent TB and depressive symptoms in household contacts of persons with active TB	23
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries	22
CFU counting may underestimate TB bacilli number of blood, biasing limit of detection estimates in spiking experiments	22
Yield of community outreach events for TB screening	22
WHO target product profiles for TB preventive treatment	21
TB in ageing populations: lessons from Japan and Korea	20
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease	18
CAD4TB software updates: different triaging thresholds require caution by users and regulation by authorities	18
Haematological indicators of mortality in people with community-acquired pneumonia living at high altitude	17
The COVID-19 pandemic does not bode well for TB control	17

Reply to: Observations on malnutrition and anti-TB drugs in Ghana	16
Are schools prepared to manage students with an asthma attack?	16
Literature Highlights	16
Assessment of TB patient cost – what about the mitigation strategy?	15
Advantages and limitations of virtual multi-disciplinary team meetings on difficult-to-treat mycobacteria	14
Lichenoid drug eruption in patients on anti-TB therapy in a high HIV prevalence setting	14
Standards for clinical trials for treating TB	14
Gender differences in health-seeking behaviour, diagnosis and treatment for TB	14
Assessing patient satisfaction with video-supported therapy for drug-susceptible TB treatment	13
Occupational transmission of TB infection during autopsy	13
Sputum culture conversion definitions and analytic practices for multidrug-resistant TB	13
Impact of revised definitions for extensively drug-resistant TB on disease classification	13
TB testing in HIV-positive patients prior to antiretroviral treatment	13
Accessibility and TB patient satisfaction in Nigeria	13
Performance of spirometry assessment at TB diagnosis	13
Treatment outcomes and safety of bedaquiline, delamanid, and linezolid in multidrug-resistant TB	12
Introduction of the Simple One-Step stool Xpert Ultra method to detect TB in children and adults	12
TB disease yield from household contact screening of TB index patients in Pakistan	12
Perceived stigma among people with TB and household contacts	12
Patterns of TB transmission in the United States, 2011–2017	11
Prevalence of chronic airflow obstruction in sub-Saharan Africa	11
Post-TB lung disease: keep going beyond TB!	11
A cohort study exploring variables associated with mortality in critically ill TB patients	11
Risk factors for severe COPD exacerbation in Chinese adults	11
Factors associated with false-negative for T-SPOT.TB in patients with TB disease	10
Facilitators and barriers to adolescent participation in a TB clinical trial	10
Paediatric TB care in the United Kingdom	10
Emphasis on post-TB lung disease and other sequelae of TB is good but a public health approach to TB is morally ambitious	10
Incidence of TB among kidney transplant recipients in a setting with universal isoniazid prophylaxis	10
A novel method for contact tracing for TB at household and community level	10
TB case fatality and recurrence in a private sector cohort in Mumbai, India	9
Population attributable fraction for smoking and diabetes in TB	9
Impact of COVID-19 on extrapulmonary TB and the benefit of decentralised TB services	9
EJ-antisynthetase syndrome presenting as severe acute respiratory distress syndrome	9
Updated guidelines for child and adolescent TB	9
Health status of Italian children living close to cultivations sprayed with pesticides	9
Initial experience with BPaL-based regimens to treat multidrug-resistant TB	9
Opportunities to prevent and manage undernutrition to amplify efforts to end TB	8
Does distance to healthcare facility affect care-seeking for TB-related symptoms in Tanzania?	8
Perceived stigma related to TB preventive therapy	8
Cascade of care for people with TB and diabetes in India	8
Higher yield using an event-based vs. door-to-door approach for active case-finding for TB	8
Bedaquiline-based all-oral regimen for macrolide-resistant Mycobacterium abscessus pulmonary disease	8
Meeting of two pandemics in prison: a challenging event in a challenging environment	8
Clinical standards for the diagnosis and management of asthma in low- and middle-income countries	8
Decentralising TB diagnosis and contact management: impact on detection and preventive treatment in children	8
Medical management of large and multiple pulmonary echinococcal cysts	8
Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan	7
Lower TB notification rates in later life in the same birth cohort, Japan, 1950–2020	7
If you want to go far, go together: standardisation and data sharing in TB drug development	7

Use of computed tomography for the diagnosis of TB during a paediatric outbreak	7
Protecting healthcare workers from TB	7
Population pharmacokinetics of bedaquiline in patients with drug-resistant TB	7
Characteristics, risk factors and outcomes of critically ill patients with active TB	7
TB notifications among citizens and non-citizens in Taiwan	7
Post-hospitalisation respiratory and physical functions in patients with SARS-CoV-2 delta	7
Clinical features, microbiology and lung function in post-TB bronchiectasis compared to other aetiologies	7
An approach for improving the quality of country-level TB modelling	7
The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia	7
Mortality and causes of death in non-tuberculous mycobacterial pulmonary disease	7
The effect of systematic screening of the general population on TB case notification rates	7
Evaluation of QFT-Plus performance using blood samples stored at room temperature	7
Supplementary inspired oxygen fraction is a simple clinical tool that predicts clinical deterioration	6
Prevalence and determinants of chronic respiratory diseases in adults in rural Sudan	6
Financial impact of COVID-19 on TB patients in India	6
Real-world implementation of video-observed therapy in an urban TB program in the United States	6
Effect of biological therapies on TB treatment outcomes	6
TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil	6
Cutaneous adverse drug reactions to fixed-dose combination treatments for TB	6
A new understanding of clinical patterns in post-TB lung disease	6
Extemporaneously compounded liquid formulations of clofazimine	6
The high costs facing TB-affected households in Mali	6
A scoping review of interventions to mitigate common non-communicable diseases among people with TB	6
Clinical experience of TB in patients treated with anti-TNF-α	6
Cost of TB prevention and treatment in the Philippines in 2017	6
Proportions of Xpert MTB/RIF Ultra ‘trace’ results vary widely among different populations with presumptive TB	6
Pulmonary TB and chronic pulmonary aspergillosis: clinical differences and similarities	6
Rifampicin-resistant TB: discordance between Xpert® MTB/RIF and MTBDRplus results	6
Evaluation of testing face-mask filter samples with LAMP shows high rates of detection in pulmonary TB	6
Time to integrate epidemiological and economic models for TB	6
Urine LAM diagnostics can close the deadly testing gap for TB	6
Towards quality adolescent-friendly services in TB care	6
TB and chronic pulmonary aspergillosis: a few relevant points	6
TB therapeutic drug monitoring – analysis of opportunities in Romania and Ukraine	6
Contribution of Xpert® MTB/RIF to pediatric TB diagnosis in Mozambique	6
Community-based intervention and health education to scale up TB preventive treatment for children	6
Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB	6
Paediatric formulations for the treatment of drug resistant TB: closing the gaps	6
Predictors of TB disease in HIV-exposed children from Southern Africa	6
Impact of COVID-19 on hospitalisations for asthma	6
TB disease in children from the prehistoric era	6
Literature Highlights	5
A home-based care programme for rifampicin-resistant TB	5
Early line-probe assay using DNA specimens in patients with pulmonary TB	5
High prevalence of multidrug-resistant TB among household contacts in a high burden setting	5
Sputum pooling for rapid and cost-effective active case-finding for TB in prisons	5
Rapid molecular diagnostics to detect resistance to second-line anti-TB drugs	5
Bronchiectasis exacerbations: certainties and future challenges	5
Exhaled breath specimens subjected to point-of-care lipoarabinomannan testing	5
Glutathione and N-acetylcysteine in TB management	5
National approaches to TB care in adolescents	5
Factors associated with presenting to private sector care providers at the onset of TB symptoms	5
A bold new future for the IJTLD	5
Quality assessment of clinical practice guidelines for the management of wheezing disorders in children	5
Chronic pulmonary aspergillosis as a sequel to pulmonary TB	5
TB screening of Ukrainian refugees in Germany	5
Fluoroquinolone preventive therapy for children exposed to MDR-TB	5
TB and COVID-19 co-infection in a pulmonology hospital	5
Estimating TB survival ‐ mind the immortal-time gap	5
WHO drug-resistant TB guidelines 2022: what is new?	5
Metabolic characterisation of adult Ugandan patients with TB and diabetes mellitus comorbidity	5
Implementation of modified, all-oral shorter TB regimens in Armenia	5
A study of persistent symptoms and pulmonary function at 3 months post moderate or severe COVID-19 in Angola	5
Geographical differences in chronic obstructive pulmonary disease mortality trends by sex, Spain, 1980–2021	5
After DOT, the brave new world?	5
A systematic review on the effect of diabetes mellitus on the pharmacokinetics of TB drugs	5
TB mortality in low-incidence countries: can we reduce it further?	5
Determinants of treatment outcomes in patients with multidrug-resistant TB	5
New diagnostics for the spectrum of asymptomatic TB: from infection to subclinical disease	5
Responding to the post-pandemic crisis: post-exposure prophylaxis for TB	5
Population attributable fraction for undernutrition due to TB does not take account of bidirectional causality	5
Diabetes characteristics and long-term management needs in diabetic TB patients	5
Use of stool swabs in molecular transport media increases access to Xpert Ultra testing for TB in children	5
Family directly observed therapy for children with drug-resistant TB	5
An epidemiological analysis of TB trends in native and migrant populations, New Mexico, 1993–2021	5
Is it time for new fixed-dose combinations and revised weight bands for children with drug-susceptible TB?	4
The rise of artificial intelligence reading of chest X-rays for enhanced TB diagnosis and elimination	4
Lessons learned from treating drug-resistant TB and how to apply these to drug-susceptible TB	4
Prevalence of and risk factors for depressive symptoms in non-tuberculous mycobacterial pulmonary disease	4
Impact of the COVID-19 pandemic on TB infection testing	4

Launch of the IJTLD Clinical Standards for Lung Health	4
Factors associated with patient delay in the diagnosis of TB – a study of health-seeking behaviour	4
National survey on the impact of the war in Ukraine on TB diagnostics and treatment services in 2022	4
Use of rapid molecular TB diagnostics for incarcerated people in Brazil	4
Evidence and ethical considerations for the treatment of contacts exposed to drug-resistant TB	4
TB screening of children from Ukraine in Germany	4
Diabetes mellitus and TB – finding strategies to reduce the double burden of disease	4
Potential use of nasopharyngeal aspirate for pediatric TB diagnosis	4
Evaluation of the MolecuTech® REBA MTB-XMDR kit for detection of pre-extensively drug-resistant TB	4
Interventions to enhance treatment adherence and retention in care for HIV-TB	4
Early mortality during rifampicin-resistant TB treatment	4
Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial	4
Establishing proof of concept for utility of Trueprep®-extracted DNA in line-probe assay testing	4
TB screening, prevention and treatment cascade in a Malawi prison	4
Efflux pump gene expression study using RNA-seq in multidrug-resistant TB	4
Highlighting the characteristics of TB disease in older people	3
Isolation and purification of lipoarabinomannan from urine of adults with active TB	3
Outcomes for people with TB by disease severity at presentation	3
Outcomes of TB contact tracing and predictors of success: a 10-year retrospective cohort analysis in Birmingham, UK	3
The urgent need to improve on low implementation rates for TB preventive treatment for people living with HIV	3
Long-term follow-up of persons diagnosed with multidrug-resistant TB in Chennai, India, 2013–2020	3
Attrition in the treatment cascade among elderly patients with multidrug-resistant TB	3
Outcomes of childhood TB in countries with a universal BCG vaccination policy	3
Factors associated with referrals for directly observed treatment and unsuccessful treatment	3
The economic burden of TB-affected households in DR Congo	3
Clinical outcomes in comorbid COVID-19 and TB cases	3
Preventive treatment for MDR-TB exposure in households	3
Household air pollution and COPD: cause and effect or confounding by other aspects of poverty?	3
Contribution of post-infectious bronchiolitis obliterans to non-cystic fibrosis bronchiectasis in children	3
Stable, compounded bedaquiline suspensions to support practical implementation of pediatric dosing in the field	3
Introduction of new drugs for drug-resistant TB in Iraq	3
TB in the elderly: clinical features and outcomes	3
Post-TB bronchiectasis: clinical characteristics and microbiology	3
The scientific response to TB – the other deadly global health emergency	3
Factors associated with screening failure and study withdrawal in multidrug-resistant TB	3
Characterising cause of death among people treated for drug-susceptible TB in India	3
Therapeutic drug monitoring for isoniazid and rifampicin exposure	3
Conjugated hyperbilirubinemia associated with accidental rifapentine overdose	3
Chronic respiratory disease in adult outpatients in three African countries: a cross-sectional study	3
Culture-negative TB: clinical characteristics, risk factors and treatment outcomes	3
Eosinophils in bronchiectasis: searching for a new endotype	3
Identifying gaps in the cascade of care for latent TB infection in a low-incidence setting	3
Bridging the gap: key evidence needed to strengthen global policies to end TB	3
Prevalence and determinants of chronic respiratory diseases in adults in Sudan	3
The effect of TB patient delay on loss to follow-up in Portugal	3
Stool-based Xpert testing for diagnosis of TB in children and critically ill adults	3
Concomitant pulmonary disease is common among patients with extrapulmonary TB	3
SMaRT-PCR: sampling using masks and RT-PCR, a non-invasive diagnostic tool for paediatric pulmonary TB	3
Increasing trend of non-tuberculous mycobacteria in a Croatian hospital, 2012–2019	3
Nosocomial TB in two neonatal intensive care units at a tertiary care centre: infection risk and outcomes	3
TB in older people in Asia: why it is important	3
Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline	3
Successful rechallenge of rifabutin in rifampicin-induced thrombocytopenia during TB treatment	3
Predictive value of neutrophil-to-lymphocyte ratio in severe pulmonary infection: sex-specific cut-off values needed	3
Ocular TB in Western Australia	3
Programmatic implications of a sub-national TB prevalence survey in India	3
TB and interstitial lung disease: a systematic review and meta-analysis	3
A comprehensive person-centred TB care model, from malnutrition to mental health	3
Work-related interstitial lung diseases: reassessing the burden	3
Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications	3
Time to care-seeking for TB symptoms	3
The 100th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19	3
Poor dietary intake at hospital admission is a predictor of mortality in patients with COVID-19	3
First report of multidrug-resistant M. tuberculosis Beijing strain isolated from the indigenous population in Tunisia	3
Risk factors for the isolation of Haemophilus influenzae in patients with stable chronic obstructive pulmonary disease	3
Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting	3
Electronic nicotine delivery system use among current smokers in India	3
Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae	3
The interplay between TB and lung cancer: risk, prognosis and treatment dynamics	3